Picture of Century Therapeutics logo

IPSC — Century Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Century Therapeutics Says Private Placement Of $60 Mln Led By Bain Capital Life Sciences Supports Expansion In Autoimmune Disease

April 11 (Reuters) - Century Therapeutics Inc  IPSC.O :
    * CENTURY THERAPEUTICS STRENGTHENS POSITION IN AUTOIMMUNE
DISEASE
WITH STRATEGIC PIPELINE EXPANSION SUPPORTED BY $60 MILLION
PRIVATE PLACEMENT AND ACQUISITION OF CLADE THERAPEUTICS
    * CENTURY THERAPEUTICS INC - PRIVATE PLACEMENT OF $60
MILLION LED
BY BAIN CAPITAL LIFE SCIENCES SUPPORTS EXPANSION IN AUTOIMMUNE
DISEASE
    * CENTURY THERAPEUTICS INC -  PRIVATE PLACEMENT REINFORCING
CASH
RUNWAY INTO 2026
    * CENTURY THERAPEUTICS INC - TO INITIATE CALIPSO-1 SLE TRIAL
H1
2024
    * CENTURY THERAPEUTICS INC: PLANS TO PURSUE ADDITIONAL
AUTOIMMUNE
DISEASE INDICATION REGULATORY FILINGS IN 2024

Source text for Eikon:  ID:nGNX53tLyt 
Further company coverage:  IPSC.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Century Therapeutics

See all news